Cargando…

Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders

Autoimmune disorders, that occur when autoreactive immune cells are induced to activate their responses against self-tissues, affect one percent of the world population and represent one of the top 10 leading causes of death. The major histocompatibility complex (MHC) is a principal susceptibility l...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fridkis-Hareli, Masha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845387/ https://www.ncbi.nlm.nih.gov/pubmed/24324511 http://dx.doi.org/10.1155/2013/826191

Ejemplares similares

Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases
por: Fridkis-Hareli, Masha
Publicado: (2008)

Peptide-Based Immunotherapeutics and Vaccines 2015
por: Reche, Pedro, et al.
Publicado: (2015)

Peptide-Based Immunotherapeutics and Vaccines 2017
por: Reche, Pedro, et al.
Publicado: (2018)

New approaches to eliciting protective immunity through T cell repertoire manipulation: the concept of thymic vaccination
por: Fridkis-Hareli, Masha, et al.
Publicado: (2004)

Peptide-Based Immunotherapeutics and Vaccines
por: Reche, Pedro A., et al.
Publicado: (2014)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
por: Thibodeau, Jacques, et al.
Publicado: (2012)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated with Autoimmune Arthritis
por: Andersson, Ida E., et al.
Publicado: (2011)

Motifs and supermotifs for MHC class II binding peptides
Publicado: (1995)

Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice
por: Spanier, Justin A., et al.
Publicado: (2023)

Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes
por: Spanier, Justin A., et al.
Publicado: (2023)

Model for the Peptide-Free Conformation of Class II MHC Proteins
por: Painter, Corrie A., et al.
Publicado: (2008)

Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination
por: Cho, Kyung-Jin, et al.
Publicado: (2013)

Identical peptides recognized by MHC class I- and II-restricted T cells
Publicado: (1989)

The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding
por: Shen, Wen-Jun, et al.
Publicado: (2018)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes
por: Obarorakpor, Nyerhovwo, et al.
Publicado: (2023)

FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study
por: Watad, Abdulla, et al.
Publicado: (2019)

A Missing Switch in Peptide Exchange for MHC Class II Molecules
por: Freund, Christian, et al.
Publicado: (2019)

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
por: Ma, Wenxue, et al.
Publicado: (2011)

Designing of interferon-gamma inducing MHC class-II binders
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2013)

Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II
por: Masaki, Kento, et al.
Publicado: (2020)

Quinpramine Ameliorates Rat Experimental Autoimmune Neuritis and Redistributes MHC Class II Molecules
por: Meyer zu Hörste, Gerd, et al.
Publicado: (2011)

Limitations of Ab Initio Predictions of Peptide Binding to MHC Class II Molecules
por: Zhang, Hao, et al.
Publicado: (2010)

Citrullination only infrequently impacts peptide binding to HLA class II MHC
por: Sidney, John, et al.
Publicado: (2017)

Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease
por: Bill, Jerome R, et al.
Publicado: (2002)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Restricted MHC–peptide repertoire predisposes to autoimmunity
por: Logunova, Nadezda N., et al.
Publicado: (2005)

Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal
por: Ferrante, Andrea
Publicado: (2013)

Prediction of MHC class II binding peptides based on an iterative learning model
por: Murugan, Naveen, et al.
Publicado: (2005)

Peptide length significantly influences in vitro affinity for MHC class II molecules
por: O'Brien, Cathal, et al.
Publicado: (2008)

The impact of DM on MHC class II–restricted antigen presentation can be altered by manipulation of MHC–peptide kinetic stability
por: Lazarski, Christopher A., et al.
Publicado: (2006)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

Transition of tumor-associated macrophages from MHC class II(hi )to MHC class II(low )mediates tumor progression in mice
por: Wang, Benfan, et al.
Publicado: (2011)

Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases
por: Welsh, Robin A., et al.
Publicado: (2020)

MHC class II complexes sample intermediate states along the peptide exchange pathway
por: Wieczorek, Marek, et al.
Publicado: (2016)

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
por: Reits, Eric A., et al.
Publicado: (2006)

MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation
Publicado: (1990)

Non-conventional sources of peptides presented by MHC class I
por: Starck, Shelley R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mttonkpl9dbv2pfshnitr5ddn8